POPULATION SCREENING FOR CHRONIC DISEASE MAXIMISING BENEFITS, MINIMISING HARMS Public Health Association of Australia (PHAA) hold conference on current and future advances in population screening
With
Adjunct Professor Terry Slevin, Chief Executive Officer
Public Health Association of Australia
Australian Health Journal Segment
Filmed in Sydney | March 2025
Population screening is an important contributor to advancing health outcomes through the early detection of and successful intervention for chronic disease. The evolution of science, technology and evidence relating to diseases which are or may be amenable to a population screening approach deserve broad discussion and the sharing of expertise and evidence. They also warrant close scrutiny in context of health policy and health resource allocation considerations.
There are established (and proposed) screening programs relevant to a range of diseases, notably breast, cervix, bowel cancer, and more recently for skin and lung cancer screening. There are a number of other chronic diseases where as new technologies are emerging and evidence is being gathered to support organised screening, (including but not limited to diabetes, CKD, MAFLD as well as cardiovascular and other risk assessment for primary prevention in general practice.
Population-based criteria for screening, based on WHO criteria and the Australian Population Based Screening Framework, aim to ensure that the benefits of screening outweigh and minimise any potential harms. These criteria are well understood by those involved in established screening programs and advocates for emerging screening programs are keen to learn from past experience how to compile evidence, design, implement and monitor programs, as well as ensure equitable participation. Similarly, there is much to learn from emerging programs and new technologies for those involved in established programs where adopting advances in evidence and technology can be challenging and perceived as slower.
In March, Public Health Association of Australia (PHAA) convened Screening Conference Conference 2025 with the theme of ‘Population Screening for Chronic Disease – Maximising Benefits, Minimising Harms’.
The conference provided opportunities for attendees to exchange information on population screening and learn from each other’s experience, across a range of disciplines. Those in attendance and presenting came from research, society, Government, program delivery, policy, consumers and clinicians.
Source: Adapted from Screening 2025 Conference website (PHAA operated)
-
Improvements in dental literacy and greater clinical insights through digital technology
Dr. Kenneth Soh is a General Dentist based in Kellyville, New South Wales, a suburb located in northwestern Sydney. Originally from Melbourne, he studied Bachelor of Dental Science (BDSc) at Melbourne University and graduated in 2003. After working for a year in the Mornington Peninsula, Dr. Soh moved to New South Wales, initially thinking it would be temporary; however, he has been there for 19 years. While he has considered specialising, he finds joy in all aspects of dentistry.
-
Report gives insights to clinical trial activity in Australia
Established in 2024, Bellberry is a Adelaide-based national, not-for-profit organisation that provides streamlined scientific and ethical reviews of human research. It is the 2025 winner of the Championing Health Award in the Telstra Best of Business Awards.
Australian Health Journal spoke with Bellberry Limited CEO, Kylie Sproston on the organisation and the findings in activity documented in the Clinical Trial Activity Report (CTAR) 2024.
-
Global GP Conference comes to Australia
Over 3000 delegates from around the World will gather at the 50th celebration of WONCA to reconnect and revive General Practice, sharing knowledge and learnings on access, equity, funding, and multidisciplinary care teams. This includes networking with Australian and overseas GPs and in particular learning about primary care practices in other countries.
Australian Health Journal met with Dr Nicole Higgins, President of RACGP in transit at Brisbane Airport recently and she spoke about the $6 Billion allocated in the Federal Budget in May as a significant achievement for General Practice investment. She also emphasised this announcement reinforced GPs should be at the centre of multidisciplinary care teams to ensure continuity of care and better health outcomes.
